Heat Biologics Inc (HTBX) stock has risen 92.53% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives HTBX stock a score of 4 out of a possible 100.
That rank is primarily influenced by a fundamental score of 1. In addition to the average rating from Wall Street analysts, HTBX stock has a mean target price of 4.375. This means analysts expect the stock to decline 26.22% over the next 12 months. HTBX's rank also includes a short-term technical score of 5. The long-term technical score for HTBX is 6.
What's Happening with HTBX Stock Today
Heat Biologics Inc (HTBX) stock is up 2.77% while the S&P 500 has risen 0.18% as of 2:16 PM on Monday, Dec 14. HTBX has risen $0.16 from the previous closing price of $5.77 on volume of 780,431 shares. Over the past year the S&P 500 is higher by 14.99% while HTBX has risen 92.53%. HTBX lost -$2.25 per share in the over the last 12 months.